Full name
AOP ORPHAN PHARMACEUTICALS POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.19.Z - Activity of agents involved in wholesale trade of non-specialized goods
58.19.Z - Other publishing activities, excluding software publishing
70.22.Z - Head office activities and management consultancy
73.11.Z - Advertising agency activities
73.20.Z - Market research and public opinion polling
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
82.30.Z - Activities related to organizing fairs, exhibitions, and congresses
85.60.Z - Educational support activities
96.09.Z - Individual service activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0 | -0,3 | -1,4 | -336,5 |
Gross profit (loss) | 0,5 | 0,3 | 0,4 | 52,6 |
EBITDA | 0,6 | 0,6 | 0,6 | -14,2 |
Short time liabilities | 6,3 | 3,7 | 1,2 | -67,7 |
Other operating costs | 0,2 | 0,1 | 0,3 | 195,2 |
Equity capital | 0,5 | 0,5 | 0,7 | 23,7 |
Operating profit (EBIT) | 0,5 | 0,4 | 0,3 | -33,8 |
Assets | 7,7 | 5,6 | 6,8 | 21,1 |
Net profit (loss) | 0,3 | 0 | 0,1 | 176,2 |
Cash | 0,3 | 1 | 2,5 | 147,4 |
Net income from sale | 14,2 | 14 | 19,3 | 38,1 |
Liabilities and provisions for liabilities | 7,2 | 5,1 | 6,2 | 20,9 |
Working assets | 7,4 | 4,6 | 5,9 | 26,7 |
Other income costs | 0,6 | 0,8 | 1,9 | 133,7 |
Depreciation | 0,1 | 0,2 | 0,3 | 20,6 |
% | % | % | p.p. | |
Profitability of capital | 71,3 | 8,6 | 19,1 | 10,5 |
Equity capital to total assets | 6,3 | 9,4 | 9,6 | 0,2 |
Gross profit margin | 3,2 | 1,9 | 2,1 | 0,2 |
EBITDA Margin | 4,1 | 4,6 | 2,9 | -1,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 163 | 97 | 23 | -74 |
Current financial liquidity indicator | 1.1680407524108887 | 1.247244954109192 | 4.890038013458252 | 3,7 |
Net dept to EBITDA | 4.35209321975708 | 3.030395030975342 | 0.5504662990570068 | -2,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane